Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Exchange Rate Effect: 2009-2025

Historic Exchange Rate Effect for China Pharma Holdings (CPHI) over the last 16 years, with Sep 2025 value amounting to $42,392.

  • China Pharma Holdings' Exchange Rate Effect rose 313.86% to $42,392 in Q3 2025 from the same period last year, while for Sep 2025 it was -$66,842, marking a year-over-year decrease of 237.98%. This contributed to the annual value of -$66,232 for FY2024, which is 307.46% down from last year.
  • China Pharma Holdings' Exchange Rate Effect amounted to $42,392 in Q3 2025, which was up 206.98% from -$39,627 recorded in Q2 2025.
  • China Pharma Holdings' 5-year Exchange Rate Effect high stood at $50,439 for Q4 2023, and its period low was -$153,626 during Q3 2022.
  • Moreover, its 3-year median value for Exchange Rate Effect was -$5,371 (2025), whereas its average is -$3,356.
  • Data for China Pharma Holdings' Exchange Rate Effect shows a peak YoY increase of 1,283.72% (in 2022) and a maximum YoY decrease of 3,654.30% (in 2022) over the last 5 years.
  • Quarterly analysis of 5 years shows China Pharma Holdings' Exchange Rate Effect stood at -$14,578 in 2021, then skyrocketed by 126.57% to $3,874 in 2022, then soared by 1,201.99% to $50,439 in 2023, then slumped by 227.35% to -$64,236 in 2024, then soared by 313.86% to $42,392 in 2025.
  • Its last three reported values are $42,392 in Q3 2025, -$39,627 for Q2 2025, and -$5,371 during Q1 2025.